Multi-layer guilt-by-association-based drug repurposing by integrating clinical knowledge on biological heterogeneous networks
Bang, D.; Lim, S.; Lee, S.; Kim, S.
Show abstract
Computational drug repurposing attempts to leverage rapidly accumulating high-throughput data to discover new indications for existing drugs, often by clarifying biological mechanisms with relevant genes. Leveraging the Guilt-by-association (GBA), the principle of "similar genes share similar functions," we introduced clinical neighbors of drug and disease entities while learning their mechanisms on the biological network. To overcome the hurdle of connecting drugs and diseases through large and dense gene-gene network and simultaneously realize the concept of "semantic multi-layer GBA", we present a random walk-based algorithm with a novel clinical-knowledge guided teleport. As a result, drug-disease association prediction accuracy increased up to 8.7% compared to existing state-of-the-art models. In addition, exploration of the generated embedding space displays harmony between biological and clinical contexts. Through repurposing case studies for breast carcinoma and Alzheimers disease, we demonstrate the potential power of multi-layer GBA, a novel perspective for predicting clinical-level associations on heterogeneous biomedical networks.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Gra-CRC-miRTar: The pre-trained nucleotide-to-graph neural networks to identify potential miRNA targets in colorectal cancer 95%
- G-PLIP: Knowledge graph neural network for structure-free protein-ligand bioactivity prediction 95%
- TCMM: A Unified Database for Traditional Chinese Medicine Modernization and Therapeutic Innovations 95%
Similar papers in this journal
Similar papers in this journal
- COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19 96%
- Repurposing Non-pharmacological Interventions for Alzheimer’s Diseases through Link Prediction on Biomedical Literature 96%
- Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines 96%
Similar papers in this journal
- AE-LGBM: Sequence-Based Novel Approach To Detect Interacting Protein Pairs via Ensemble of Autoencoder and LightGBM. 93%
- Predicting Disease-gene Associations through Self-supervised Mutual Infomax Graph Convolution Network 93%
- Predicting the physiological effects of multiple drugs using electronic health record 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.